NCT04124458 is a NA clinical trial of Radiofrequency ablation in Occipital Neuralgia, sponsored by Allevio Pain Management Clinic.

Who is sponsoring NCT04124458?

NCT04124458 is sponsored by Allevio Pain Management Clinic.

What drugs are being tested in NCT04124458?

Interventions in NCT04124458: Radiofrequency ablation.

What condition does NCT04124458 study?

NCT04124458 studies Occipital Neuralgia, Headache.

Is NCT04124458 still recruiting?

NCT04124458 is currently status unknown. Last updated 15 February 2022.

Last reviewed 2022-02-15 · How we verify

NCT04124458

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Occipital Nerve RF Between Occipital Nerve Block And Occipital Nerve Radiofrequency Ablation

Status unknown NA Last updated 15 February 2022

What this trial tests

NA trial testing Radiofrequency ablation in Occipital Neuralgia in 70 participants. Status unknown.

Timeline

2 January 2023

Primary endpoint
31 October 2025

31 December 2025

Quick facts

Lead sponsor	Allevio Pain Management Clinic
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	70
Start date	2 January 2023
Primary completion	31 October 2025
Estimated completion	31 December 2025

Drugs / interventions tested

Radiofrequency ablation

Conditions studied

Occipital Neuralgia — all drugs for Occipital Neuralgia →
Headache — all drugs for Headache →

Sponsor

Allevio Pain Management Clinic

Who can join

Adults 18 to 90, any sex, with Occipital Neuralgia or Headache. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a randomized, double blind, single-center, clinical trial. The study will be conducted over a period of 6 months. The study will be conducted at the Allevio Pain Clinic, Toronto, Canada.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Radiofrequency ablation

Trials testing the same drug.

NCT05930756 — 3-point vs 6-point GNRFA for Chronic KOA · NA · not yet recruiting
NCT06850064 — Efficacy and Safety of Pulsed Field Ablation in Refractory Mitral Isthmus-dependent Atrial Flutter: Pulsed Field Ablatio · NA · not yet recruiting
NCT06863181 — Comparison of Conventional and Cooled Radiofrequency Ablation in Knee Osteoarthritis · NA · completed
NCT06170736 — Radiofrequency Ablation vs Doppler-guided Haemorrhoidal Artery Ligation in the Treatment of Haemorrhoidal Disease · NA · recruiting
NCT06134752 — Electroporation for Treatment of Atrial Fibrillation · NA · active not recruiting

Other Allevio Pain Management Clinic trials

Trials by the same sponsor.

NCT04124445 — Pulsed vs Continuous Radiofrequency Neurotomy for Cervical Facet Joint Mediated Pain · NA · unknown
NCT04123652 — Ambulatory Infusions of Lidocaine and Ketamine for Management of Chronic Pain · Phase 4 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04124458 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Allevio Pain Management Clinic
Last refreshed: 15 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04124458.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing